The safety and efficacy of timolol 0.5% in xanthan gum versus timolol gel forming solution 0.5%

Current Eye Research

Volumn 24, Issue 5, 2002, Pages 387-391

  Stewart, William C ^a,b   Sharpe, Elizabeth D ^c   Stewart, Jeanette A ^a   Hott, E Chaney ^a  

^a University of South Carolina   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c Charleston Research Company LLC   (United States)

Author keywords

Forming; Gel; Solution; Timolol

Indexed keywords

GELLAN; TIMOLOL; XANTHAN;

ADULT; ALLERGY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; EYE BURNING; FEMALE; HUMAN; INTRAOCULAR PRESSURE; LACRIMATION; MALE; OPEN ANGLE GLAUCOMA; PHOTOGRAPHY; PRIORITY JOURNAL; STAINING; VERTIGO; VISUAL IMPAIRMENT;

EID: 0036941670     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1076/ceyr.24.5.387.8516     Document Type: Article

References (11)

1. Stewart WC. Current and future glaucoma therapy. Ciba Clinical Symposium. 1997.
2. Schlecht LP, Brubaker RF. The effects of withdrawal of timolol in chronically treated glaucoma patients. Ophthalmology. 1988;95:1212-1216.
3. Book SA. Essentials of Statistics. New York: McGraw Hill; 1978:117-122, 205-215.
4. Mundorf TK, Cate EA, Sine CS, Otero DW, Stewart JA, Stewart WC. The safety and efficacy of switching timolol maleate 0.5% solution to timolol hemihydrate 0.5% solution given twice daily. J Ocular Pharm and Therap. 1998;14:129-135.
5. Duff GR. A double-masked crossover study comparing the effects of carteolol 1% and 2% on intraocular pressure. Acta Ophthalmologica. 1987;65:618-621.
6. Siegel S. Non Parametric Statistics. Series in Psychology. New York: McGraw Hill; 1956:63-67.
7. Neter J, Wasserman W, Kutner M. Applied Linear Regression Model. Boston: Irwin; 1989:164.
8. Schooner HI, Silver LH, The Timolol Gel-Forming Solution Study Group. Long-term intraocular pressure-lowering efficacy and safety of timolol maleate gel-forming solution 0.5% compared with Timoptic XE 0.5% in a 12-month study. Am J Ophthalmol. 2000;130;145-150.
9. Meseguer G, Buri P, Plazonnet B. Gamma scintigraphic comparison of eyedrops containing pilocarpine in healthy volunteers. J Ocul Pharmacol. 1996;12:481-488.
10. Greaves JL, Wilson CG, Rozier A et al. Scintigraphic assessment of an ophthalmic gelling vehicle in man and rabbit. Curr Eye Res. 1990;9:415-420.
11. rd. Shortterm "escape" and longterm "drift": The dissipation effects of the beta adrenergic blocking agents. Surv Ophthalmol. 1983;28(Supp):235-242.